The Effect of Intervention Recombinant IL-10 on Level of TNF-α and GFAP Serum in the Wistar Rats with Traumatic Brain Injury Treatment

Yusfitaria Alvina¹, Andi Asadul Islam², Willy Adhimartha², Idham Jaya Ganda³ and Prihantono Prihantono^1,

¹Department of Surgery, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia

²Neuro Surgery Division, Department of Surgery, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia

³Department of Pediatric, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia

Cite this paper:
Yusfitaria Alvina, Andi Asadul Islam, Willy Adhimartha, Idham Jaya Ganda and Prihantono Prihantono. The Effect of Intervention Recombinant IL-10 on Level of TNF-α and GFAP Serum in the Wistar Rats with Traumatic Brain Injury Treatment. American Journal of Medical and Biological Research. 2017; 5(1):9-12. doi: 10.12691/ajmbr-5-1-2

Abstract

Traumatic brain injury (TBI) can trigger an inflammation and activation the mediator substances. TNF-α is a major cytokine that has adverse effects in high level. Glial Fibrillary Acidic Protein (GFAP) in brain cells increases in TBI thus can be an accurate biomarker for brain damage. The purposes of this study are to know the intervention effect of IL-10 as an anti-inflammatory to inflammatory processes (pro anti-inflammatory balance) in TBI. This is an experimental laboratory study with a post-test control group design consisting of four treatment groups and one control group. Measurement of Tumor Necrosis Factor α (TNF-α) and GFAP using Enzyme-Linked Immunoabsorbent Assay (ELISA) methods. The result of this study shows Groups with provoked brain injury had significantly higher levels of serum TNF-α (p <0.05) than the control group. Group provoked a brain injury and given recombinant IL-10 did not have increased levels of TNF-α in serum after 1 hour, differ significantly with no intervention of IL-10. The levels of GFAP have no significant difference 1 hour after TBI, and these levels increase at 24 hours. The conclusion is Intervention by IL-10 could decrease the levels of TNF-α serum immediately after TBI in the Wistar rats and the levels of GFAP 24 hours after TBI are increasing persistently although given by intervention of IL-10 or not.

Keywords:
Glial Fibrillary Acidic Protein Interleukin-10 traumatic brain injury

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	ShohamiE., Stahel PF, Younis FM, Kariya K, Experimental Closed Head Injury: Analysis of Neurological Outcome, Blood Brain Barrier Death in Mice Deficient in Gene for Proinflammatory Cytokines, J Cereb Blood Flow Metab, 2000; Feb; 20(2): 369-80.
[2]	Beaumont A, Marmau A. Response of the brain to physical injury: neurosurgery the scientific basis of clinical practice. Edisi ke-3. Volume 1. London: Blackwell Science Ltd; 2000.
[3]	Iskandar J.Cedera Kepala. Jakarta: PT Bhuana Ilmu Populer; 2004.
[4]	Narayan RK, Wilberger JE, Povlishock JT.Neurotrauma; neuropathology of head injury, emergency room management of the head-injured patient. USA: Mc Graw Hill; 1996.
[5]	Setti RS, Richard EG. The principle of neurosurgery: increase intracranial pressure, cerebral edema, and brain herniation. Edisi ke-2. Philadelphia USA: Elsevier Mosby; 2005.
[6]	Julian YR. Neurological surgery: intracranial pressure. Edisi ke-4. Volume 1. California USA: W.B. Sounders Company; 1996.
[7]	Shohami E., Ginis, I., Hallenbac, JM., Dual Role of Tumor Necrosis Factor Alpha in Brain Injury, Cytokine Growth Factor Rev, 1999: Jun;10(2):119-30.
[8]	Knoblach, SM., Faden, AI., Interleukin-10 Improves Outcome and Alter Proinflammatory Cytokine Expression After Experimental Traumatic Brain Injury, ExpNeurol, 1998, Sep;153(1):143-51.
[9]	Direct Surgical Trauma Care (DSTC) Manual, 2008. Patofisiologi Trauma. pp 2-18.
[10]	Hergenroeder GW, Redell JB, Moore AN, Dash PK. Biomarkers in the Clinical Diagnosis and Management of Traumatic Brain Injury. Molecular Diagnosis and Therapy 2008; 12 (6). 345-58
[11]	Pelinka L. E, Serum markers of severe traumatic brain injury: Are they useful?, Review article, Indian Journal of Critical Care Medicine, vol. 8, 2004.
[12]	May L. Anatomy and Physiology. In: May L, ed. Pediatric Neurosurgery. London: Whurr Publisher. 2001. p. 1-25.
[13]	Taufik M. Cedera Kepala. [online]. 2010. [cited January, 15th 2011] Available from URL: http://tinjauan-pustaka-anatomi-dan-fisiologi.html
[14]	Lombardo MC. Cedera Sistem Saraf Pusat. Dalam: Price SA, Wilson LM, eds. Patofisiologi: Konsep Klinis Proses-Proses Penyakit. Edisi 6. Volume 2. Jakarta: Penerbit Buku Kedokteran EGC. 2006. hal. 1167-82.
[15]	Japardi I. Cairan Cerebrospinal. [online]. 2001. [cited January, 15th 2011] Available from USU digital library.
[16]	L.Rahim, N.P. Edema Serebri dalam Cermin Dunia Kedokteran, FKUH Makassar,1985;40-3.
[17]	Bradley J.R., TNF-Mediated Inflammatory Disease in Journal of Pathology, Cambridge, UK, 2008;214:149-160.
[18]	Zoltewicz J.S., Scharf D., Yang B., et al., Characterization of antibodies that detect human GFAP after Traumatic Brain Injury, 2012 June, 7:71-79.
[19]	Mesotten D, Vanhorebeek, Van den Berghe G. Glucose and Insulin Management in Critical Care in Trauma Critical Care Volume 2. 2003. 1075-80.
[20]	Islam, A.A., Peran Sitokin Inflamasi dan Anti Inflamasi dalam Meramal Luaran Penderita Cedera Otak Tertutup yang Dilakukan Tindakan Operasi, Disertasi Doktor, Program Pascasarjana, Universitas Hasanuddin, Makassar, 2006: 80-99.